CERO THERAPEUTICS HOLDINGS, INC.
corporate_fare Company Profile
CERO THERAPEUTICS HOLDINGS, INC. (OTC:CEROW) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for CEROW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-07, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for CEROW spans 8-K.
Recent high-impact activity:
- CERo Therapeutics Sells Operating Subsidiary to SRX Global in Debt-for-Asset Deal
- CERo Therapeutics Secures $11.7M Senior Secured Financing, Pledges All Subsidiary Assets Including CER-1236 IP
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 9,375 shares in CEROW as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.